Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-19T05:45:01.869Z Has data issue: false hasContentIssue false
  • English
  • Français

Percutaneous closure of ventricular septal defect using LifeTechTM Konar-MF VSD Occluder: initial and short-term multi-institutional results

Part of: Echocardiography

Published online by Cambridge University Press:  28 July 2021

Masood Sadiq Open the ORCID record for Masood Sadiq [Opens in a new window] ,
Ahmad Usaid Qureshi ,
Muhammad Younas ,
Sohail Arshad  and
Syed Najam Hyder
Masood Sadiq*
Affiliation:
Department of Pediatric Cardiology, The Children’s Hospital and Institute of Child Health, Lahore, Pakistan
Ahmad Usaid Qureshi
Affiliation:
Department of Pediatric Cardiology, The Children’s Hospital and Institute of Child Health, Lahore, Pakistan
Muhammad Younas
Affiliation:
Department of Pediatric Cardiology, CPE Institute of Cardiology, Multan, Pakistan
Sohail Arshad
Affiliation:
Department of Pediatric Cardiology, The Children’s Hospital and Institute of Child Health, Multan, Pakistan
Syed Najam Hyder
Affiliation:
Department of Pediatric Cardiology, The Children’s Hospital and Institute of Child Health, Lahore, Pakistan
*
Author for correspondence: Professor Masood Sadiq MRCP (UK), FRCP(Ed), FRCPCH Department of Paediatric Cardiology, The Children’s Hospital and Institute of Child Health, Ferozepur Road, Lahore, Pakistan. Tel: 0092-42-99231723; Fax: 0092-42-99230358. E-mail: drmasoodsadiq@hotmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Transcatheter ventricular septal defect closure remains a complex procedure with potential complications like complete heart block and aortic regurgitation. The ideal device design for such intervention is still evolving.

Aim:

To assess the safety, efficacy, and short-term outcome of ventricular septal defect closure using LifeTechTM multifunctional (KONAR-MFTM) VSD Occluder.

Patients and methods:

In a multicenre study, 44 patients with haemodynamically significant, restrictive ventricular septal defects underwent closure with the KONAR-MFTM device from April, 2019 to March, 2020. Clinical, echocardiographic, and angiographic data were collected and reviewed. Patients were followed up at 1, 3, 6, and 12 months.

Results:

The median age and weight were 8 (1.7–36) years and 20 (11–79) kg. Of 44 patients, 8 (18%) had a high muscular and 36 (82%) had a perimembranous defect, of which 6 had mild prolapse of the right coronary cusp. The median ventricular septal defect size was 8.8 (3.9–13.4) mm. A retrograde approach was adopted in 39 (88.6%) patients. Nine patients (20.5%) had a small residual leak and there was a slight increase in aortic regurgitation in one patient. One device, which embolised to pulmonary artery was retrieved, and the defect was closed with a larger device. At a median follow-up of 13 (5–18) months, the residual leak persisted in 1 (2.3%) patient. Mild aortic regurgitation in one patient remained unchanged. There were no major complications.

Conclusion:

Percutaneous closure of ventricular septal defect using KONAR-MFTM device is safe and effective in short and midterm follow-up including selected patients with perimembranous defect and mild prolapse of the right coronary cusp.

Keywords

Ventricular septal defectcongenital heart diseaseinterventionsfollow-up
Type
Original Article
Information
Cardiology in the Young , Volume 32 , Issue 5 , May 2022 , pp. 755 - 761
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Hoffman, JIE, Kaplan, S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39: 1890–1900.CrossRefGoogle ScholarPubMed
Lock, JE, Block, PC, McKay, RG, et al. Transcatheter Closure of Ventricular Septal Defects. Circulation 1988; 78: 361–368.CrossRefGoogle ScholarPubMed
Kalra, GS, Verma, PK, Dhall, A, et al. Transcatheter device closure of ventricular septal defects: immediate results and intermediate-term follow-up. Am Heart J 1999; 138: 339–344. doi: 10.1016/s0002-8703(99)70122-5. PMID: 10426849.CrossRefGoogle ScholarPubMed
Sideris, EB, Walsh, KP, Haddad, JL, et al. Occlusion of congenital ventricular septal defects by the buttoned device. “Buttoned device” Clinical Trials International Register. Heart 1997; 77: 276–279. doi: 10.1136/hrt.77.3.276.CrossRefGoogle ScholarPubMed
Knauth, AL, Lock, JE, Perry, SB, et al. Transcatheter device closure of congenital and postoperative residual ventricular septal defects. Circulation 2004; 110: 501–507. doi: 10.1161/01.CIR.0000137116.12176.A6. Epub 2004 Jul 19. PMID: 15262841.CrossRefGoogle ScholarPubMed
Hijazi, ZM, Hakim, F, Haweleh, AA, et al. Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: initial clinical experience. Catheter Cardiovasc Interv 2002; 56: 508–515. doi: 10.1002/ccd.10292. PMID: 12124963.CrossRefGoogle ScholarPubMed
Pedra, CA, Pedra, SR, Esteves, CA, et al. Percutaneous closure of perimembranous ventricular septal defects with the Amplatzer device: technical and morphological considerations. Cathet Cardiovasc Intervent 2004; 61: 403–410. https://doi.org/10.1002/ccd.10797.CrossRefGoogle ScholarPubMed
Masura, J, Gao, W, Gavora, P, et al. Percutaneous closure of perimembranous ventricular septal defects with the eccentric Amplatzer device: multicenter follow-up study. Pediatr Cardiol 2005; 26: 216–219. doi: 10.1007/s00246-005-1003-7. PMID: 16082578.CrossRefGoogle ScholarPubMed
Holzer, R, de Giovanni, J, Walsh, KP, et al. Transcatheter closure of perimembranous ventricular septal defects using the Amplatzer membranous VSD occluder: immediate and midterm results of an international registry. Catheter Cardiovasc Interv 2006; 68: 620–628.CrossRefGoogle ScholarPubMed
Carminati, M, Butera, G, Chessa, M, et al. Investigators of the European VSD Registry. Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J 2007; 28: 2361–2368.CrossRefGoogle ScholarPubMed
Butera, G, Carminati, M, Chessa, M, et al. Transcatheter closure of perimembranous ventricular septal defects: early and long-term results. J Am Coll Cardiol 2007; 50: 1189–1195. doi: 10.1016/j.jacc.2007.03.068. Epub 2007 Sep 4. PMID: 17868812.CrossRefGoogle ScholarPubMed
Santhanam, H, Yang, L, Chen, Z, et al. A meta-analysis of transcatheter device closure of perimembranous ventricular septal defect. Int J Cardiol 2018; 254: 75–83.10.1016/j.ijcard.2017.12.011CrossRefGoogle ScholarPubMed
Predescu, D, Chaturvedi, RR, Friedberg, MK, et al. Complete heart block associated with device closure of perimembranous ventricular septal defects. J Thorac Cardiovasc Surg 2008; 136: 1223–1228.10.1016/j.jtcvs.2008.02.037CrossRefGoogle ScholarPubMed
Zhou, T, Shen, XQ, Zhou, SH, et al. Complications associated with transcatheter closure of perimembranous ventricular septal defects. Catheter Cardiovasc Interv 2008; 71: 559–563.CrossRefGoogle ScholarPubMed
Yang, R, Kong, XQ, Sheng, YH, et al. Risk factors and outcomes of post-procedure heart blocks after transcatheter device closure of perimembranous ventricular septal defect. JACC Cardiovasc Interv 2012; 5: 422–427.CrossRefGoogle ScholarPubMed
Haas, NA, Kock, L, Bertram, H, et al. Interventional VSD-Closure with the Nit-Occlud® Lê VSD-Coil in 110 Patients: early and Midterm Results of the EUREVECO-Registry. Pediatr Cardiol 2017; 38: 215–227.CrossRefGoogle ScholarPubMed
Kozlik-Feldmann, R, Lorber, A, Sievert, H, et al. Long-term outcome of perimembranous VSD closure using the Nit-Occlud® Lê VSD coil system. Clin Res Cardiol 2021; 110: 382–390. https://doi.org/10.1007/s00392-020-01750-6.CrossRefGoogle ScholarPubMed
Mijangos-Vázquez, R, El-Sisi, A, Sandoval Jones, JP, et al. Transcatheter Closure of Perimembranous Ventricular Septal Defects Using Different Generations of Amplatzer Devices: multicenter Experience. J Interv Cardiol 2020; 2020: 8948249. doi: 10.1155/2020/8948249. PMID: 32161516; PMCID: PMC7054803.CrossRefGoogle ScholarPubMed
Bergmann, M, Germann, CP, Nordmeyer, J, et al. Short- and Long-term Outcome After Interventional VSD Closure: A Single-Center Experience in Pediatric and Adult Patients. Pediatr Cardiol 2021; 42: 78–88. doi: 10.1007/s00246-020-02456-2. Epub 2020 Oct 3. PMID: 33009919; PMCID: PMC7864847.CrossRefGoogle Scholar
Lee, SM, Song, JY, Choi, JY, et al. Transcatheter closure of perimembranous ventricular septal defect using Amplatzer ductal occluder. Catheter Cardiovasc Interv 2013; 82: 1141–1146.10.1002/ccd.24810CrossRefGoogle ScholarPubMed
El-Sisi, A, Sobhy, R, Jaccoub, V, et al. Perimembranous Ventricular Septal Defect Device Closure: choosing Between Amplatzer Duct Occluder I and II. Pediatr Cardiol 2017; 38: 596–602.CrossRefGoogle ScholarPubMed
Tzikas, A, Ibrahim, R, Velasco-Sanchez, D, et al. Transcatheter closure of perimembranous ventricular septal defect with the Amplatzer(®) membranous VSD occluder 2: initial world experience and one-year follow-up. Catheter Cardiovasc Interv 2014; 83: 571–580. doi: 10.1002/ccd.25004. Epub 2013 Nov 13. PMID: 23703890.CrossRefGoogle ScholarPubMed
Yang, J, Yang, L, Wan, Y, et al. Transcatheter device closure of perimembranous ventricular septal defects: mid-term outcomes. Eur Heart J 2010; 31: 2238–2245.CrossRefGoogle ScholarPubMed
Esteves, CA, Solarewicz, LA, Cassar, R, et al. Occlusion of the perimembranous ventricular septal defect using CERA® devices. Cathet Cardiovasc Intervent 2012; 80: 182–187. https://doi.org/10.1002/ccd.24371.CrossRefGoogle ScholarPubMed
Zhou, D, Pan, W, Guan, L, et al. Transcatheter closure of perimembranous and intracristal ventricular septal defects with the SHSMA occluder. Catheter Cardiovasc Interv 2012; 79: 666–674.CrossRefGoogle ScholarPubMed
Schubert, S, Kelm, M, Koneti, NR, et al. First European experience of percutaneous closure of ventricular septal defects using a new CE-marked VSD occluder. EuroIntervention 2019; 15: e242–e243.CrossRefGoogle ScholarPubMed
Haddad, RN, Daou, LS, Saliba, ZS. Percutaneous closure of restrictive-type perimembranous ventricular septal defect using the new KONAR multifunctional occluder: midterm outcomes of the first middle-eastern experience. Catheter Cardiovasc Interv 2020; 96: e295–e302.CrossRefGoogle ScholarPubMed
Tanidir, IC, Baspinar, O, Saygi, M, et al. Use of Lifetech™ Konar-MF, a device for both perimembranous and muscular ventricular septal defects: A multicentre study. Int J Cardiol 2020; 310: 43–50.10.1016/j.ijcard.2020.02.056CrossRefGoogle ScholarPubMed
Kazmi, U, Sadiq, M, Hyder, SN. Pattern of ventricular septal defects and associated complications. J Coll Physicians Surg Pak 2009; 19: 342–345.Google ScholarPubMed
Chen, GL, Li, HT, Li, HR, et al. Transcatheter closure of ventricular septal defect in patients with aortic valve prolapse and mild aortic regurgitation: feasibility and preliminary outcome. Asian Pac J Trop Med 2015; 8: 315–318.CrossRefGoogle ScholarPubMed